Invention Grant
- Patent Title: Monoclonal antibodies against HER2
-
Application No.: US13700341Application Date: 2011-05-27
-
Publication No.: US09862769B2Publication Date: 2018-01-09
- Inventor: Bart De Goeij , Simone De Haij , Thilo Riedl , Rene Hoet , Ole Baadsgaard , Jan Van De Winkel , David Satijn , Paul Parren , Aran Frank Labrijn , Joyce Meesters , Janine Schuurman , Edward N. Van Den Brink
- Applicant: Bart De Goeij , Simone De Haij , Thilo Riedl , Rene Hoet , Ole Baadsgaard , Jan Van De Winkel , David Satijn , Paul Parren , Aran Frank Labrijn , Joyce Meesters , Janine Schuurman , Edward N. Van Den Brink
- Applicant Address: DK Copenhagen V
- Assignee: GENMAB A/S
- Current Assignee: GENMAB A/S
- Current Assignee Address: DK Copenhagen V
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Christopher L. Frank
- Priority: DK201000467 20100527; DK201100312 20110420; WOPCT/EP2011/056388 20110420
- International Application: PCT/EP2011/058779 WO 20110527
- International Announcement: WO2011/147986 WO 20111201
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/00 ; C07K16/28 ; C07K16/32 ; A61K39/00
Abstract:
Isolated monoclonal antibodies which bind to human epidermal growth factor receptor 2 (HER2), and related anti-body-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed.
Public/Granted literature
- US20130189271A1 MONOCLONAL ANTIBODIES AGAINST HER2 Public/Granted day:2013-07-25
Information query
